The COVID crisis has impacted IPM negatively - the growth seen in July 2020 was a mere 0.2%. This is down to -2.2% de-growth in August 2020 and shows a single digit growth of 4.1% on a MAT basis.
#Cardiac has stabilized but with lower growth of 11.5% in August 2020 - compared to 13.1% in July 2020. On a MAT basis, the growth is 11.6%.
Anti-Diabetic had a growth of 1.6 % in August 2020 compared to 5.9% in July 2020. On a MAT basis the is growth is 8.4%.
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
